{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:47:32Z","timestamp":1777106852381,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["22FC3R-018"],"award-info":[{"award-number":["22FC3R-018"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GIS-FC3R"},{"DOI":"10.13039\/501100002915","name":"Foundation for Medical Research","doi-asserted-by":"publisher","award":["FDM202206015346"],"award-info":[{"award-number":["FDM202206015346"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.placenta.2025.06.015","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T10:51:09Z","timestamp":1750762269000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3141-5925","authenticated-orcid":false,"given":"Laure-H\u00e9l\u00e8ne","family":"Pr\u00e9ta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na\u00efm","family":"Bouazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frantz","family":"Foissac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9o","family":"Froelicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00efk","family":"Urien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annouk","family":"Dauvilliers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisha","family":"Dinnall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Buth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihem","family":"Benaboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Tr\u00e9luyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Lui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2025.06.015_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/01.AOG.0000116689.75396.5f","article-title":"Prevalence of depression during pregnancy: systematic review","volume":"103","author":"Bennett","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.06.015_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/bcp.12849","article-title":"The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis","volume":"81","author":"B\u00e9rard","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.placenta.2025.06.015_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.earlhumdev.2012.01.014","article-title":"EDEN mother\u2013child cohort study group, depression and anxiety in women during pregnancy and neonatal outcome: data from the EDEN mother-child cohort","volume":"88","author":"Ibanez","year":"2012","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.placenta.2025.06.015_bib4","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/bcp.13608","article-title":"Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study: patterns of antidepressant use in pregnancy","volume":"84","author":"B\u00e9nard-Laribi\u00e8re","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.placenta.2025.06.015_bib5","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.06.015_bib6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.placenta.2025.06.015_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdra.20627","article-title":"First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies","volume":"88","author":"Wurst","year":"2010","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.placenta.2025.06.015_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.reprotox.2010.04.015","article-title":"Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs)","volume":"30","author":"Ellfolk","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.placenta.2025.06.015_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","article-title":"Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes","volume":"166","author":"Wisner","year":"2009","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.placenta.2025.06.015_bib10","article-title":"Drug-induced fetal and offspring disorders, beyond birth defects","author":"Louchet","year":"2023","journal-title":"Therapies"},{"key":"10.1016\/j.placenta.2025.06.015_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2059","article-title":"Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study","volume":"346","author":"Rai","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.placenta.2025.06.015_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapediatrics.2015.3356","article-title":"Antidepressant use during pregnancy and the risk of autism spectrum disorder in children","volume":"170","author":"Boukhris","year":"2016","journal-title":"JAMA Pediatr."},{"issue":"Suppl 7","key":"10.1016\/j.placenta.2025.06.015_bib13","first-page":"37","article-title":"Clinical management of antidepressant discontinuation","volume":"58","author":"Rosenbaum","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.placenta.2025.06.015_bib14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-8749.1994.tb08192.x","article-title":"Prenatal stressors of human life affect fetal brain development","volume":"36","author":"Lou","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2025.06.015_bib15","first-page":"S115","article-title":"Antidepressants and antipsychotics in human pregnancy: transfer across the placenta and opportunities for modeling studies","volume":"62","author":"Zheng","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.placenta.2025.06.015_bib16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9378(72)90909-X","article-title":"Transfer across the perfused human placenta of antipyrine, sodium and leucine","volume":"114","author":"Schneider","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.06.015_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2174\/1381612825666190319102812","article-title":"Methodological approaches to evaluate fetal drug exposure","volume":"25","author":"Bouazza","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.placenta.2025.06.015_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.placenta.2022.05.003","article-title":"Ex vivo dual perfusion of an isolated human placenta cotyledon: towards protocol standardization and improved inter-centre comparability","volume":"126","author":"Schneider","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2025.06.015_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1471-0528.1984.tb03700.x","article-title":"Changes in serum albumin and \u03b1 1 -acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs","volume":"91","author":"Krauer","year":"1984","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2025.06.015_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.placenta.2025.06.015_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.reprotox.2010.01.006","article-title":"Quality assessment of a placental perfusion protocol","volume":"30","author":"Mathiesen","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.placenta.2025.06.015_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1128\/AAC.01821-12","article-title":"Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression","volume":"57","author":"Vinot","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.placenta.2025.06.015_bib23","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/AAC.00007-16","article-title":"Bidirectional transfer of Raltegravir in an Ex vivo human cotyledon perfusion model","volume":"60","author":"Vinot","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.placenta.2025.06.015_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.10.802","article-title":"Placental transfer of enfuvirtide in the ex vivo human placenta perfusion model","volume":"198","author":"Ceccaldi","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.06.015_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/pd.2026","article-title":"Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model","volume":"28","author":"Kovo","year":"2008","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.placenta.2025.06.015_bib26","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.placenta.2015.07.119","article-title":"Organic anion transporter 4 (OAT 4) modifies placental transfer of perfluorinated alkyl acids PFOS and PFOA in human placental ex vivo perfusion system","volume":"36","author":"Kummu","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2025.06.015_bib27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.12815","article-title":"Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models","volume":"81","author":"De Sousa Mendes","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.placenta.2025.06.015_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/YIC.0000000000000023","article-title":"A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?","volume":"29","author":"Sanchez","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.placenta.2025.06.015_bib29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.4088\/JCP.10m06461","article-title":"Mother-infant antidepressant concentrations, maternal depression, and perinatal events","volume":"72","author":"Sit","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.placenta.2025.06.015_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.placenta.2025.06.015_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/FTD.0000000000000370","article-title":"Pharmacokinetics and pharmacogenetics of selective serotonin reuptake inhibitors during pregnancy: an observational study","volume":"39","author":"Pogliani","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.placenta.2025.06.015_bib32","first-page":"993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.placenta.2025.06.015_bib33","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1124\/dmd.113.052332","article-title":"Characterization of transplacental transfer of paroxetine in perfused human placenta: development of a pharmacokinetic model to evaluate tapered dosing","volume":"41","author":"Nagai","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.placenta.2025.06.015_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0006-3223(00)00958-6","article-title":"Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women","volume":"48","author":"Hostetter","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.placenta.2025.06.015_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S1461145704004286","article-title":"A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate","volume":"7","author":"Rampono","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.placenta.2025.06.015_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.01.019","article-title":"Sertraline in pregnancy \u2013 therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"212","author":"Paulzen","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.placenta.2025.06.015_bib37","first-page":"1262","article-title":"ACOG clinical practice guideline no. 5","volume":"141","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.06.015_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233979","article-title":"Maternal stress and placental function; ex vivo placental perfusion studying cortisol, cortisone, tryptophan and serotonin","volume":"15","author":"Mathiesen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2025.06.015_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105471","article-title":"Predicting fetal exposure of crizotinib during pregnancy: combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling","volume":"85","author":"Roelofsen","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.placenta.2025.06.015_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1742-7843.2009.00431.x","article-title":"Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: effect of albumin in the perfusion medium","volume":"105","author":"Mathiesen","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.placenta.2025.06.015_bib41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00228-021-03122-z","article-title":"Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low","volume":"77","author":"Heinonen","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.placenta.2025.06.015_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.placenta.2025.06.015_bib43","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1080\/14767058.2021.2005565","article-title":"A review of ex vivo placental perfusion models: an underutilized but promising method to study maternal-fetal interactions","volume":"35","author":"Calis","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425002218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425002218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:18:29Z","timestamp":1777105109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425002218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":43,"alternative-id":["S0143400425002218"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.06.015","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}